Dual inhibition of HSP27 and FAO as a novel therapeutic strategy for cisplatin-resistant ovarian cancer

被引：0
|
作者：
Heiserman, James P.
Minhas, Zenab
Cheon, Dong-Joo
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-1761
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1761
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Beta-oxidation inhibition as a novel therapy for cisplatin-resistant ovarian cancer
    Rada, Miran
    Cha, Jennifer
    Sage, Jessica
    Zhou, Bo
    Yang, Wei
    Ashkavand, Zahra
    Norman, Kenneth
    Orsulic, Sandra
    Cheon, Dong-Joo
    CANCER RESEARCH, 2018, 78 (13)
  • [2] Inhibition of heat shock protein 27 (Hsp27) expression by apatorsen as a therapeutic strategy in breast cancer
    Komulainen, Emilia
    Shia, Alice
    Bansal, Jasmin
    Cavicchioli, Francessa
    O'Leary, Karen
    Foster, John
    Schmid, Peter
    CANCER RESEARCH, 2016, 76
  • [3] TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer
    Liu, Yixuan
    Zhu, Keyu
    Guan, Xiaolin
    Xie, Suhong
    Wang, Yanchun
    Tong, Ying
    Guo, Lin
    Zheng, Hui
    Lu, Renquan
    JOURNAL OF OVARIAN RESEARCH, 2021, 14 (01)
  • [4] TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer
    Yixuan Liu
    Keyu Zhu
    Xiaolin Guan
    Suhong Xie
    Yanchun Wang
    Ying Tong
    Lin Guo
    Hui Zheng
    Renquan Lu
    Journal of Ovarian Research, 14
  • [5] Gemcitabine in cisplatin-resistant ovarian cancer
    Lund, B
    Neijt, JP
    SEMINARS IN ONCOLOGY, 1996, 23 (05) : 72 - 76
  • [6] A RNAi screening to identify novel targets in cisplatin-resistant ovarian cancer
    Noriega, Ricardo
    Perez, Josue
    Vivas, Pablo
    FASEB JOURNAL, 2021, 35
  • [7] c-MYC is a potential therapeutic target for cisplatin-resistant ovarian cancer
    Vivas-Mejia, Pablo E.
    Reyes, Jeyshka
    Sood, Anil K.
    MOLECULAR CANCER RESEARCH, 2015, 13
  • [8] Heat shock protein 27 (HSP27) in patients with ovarian cancer
    Bodzek, Piotr
    Damasiewicz-Bodzek, Aleksandra
    Janosz, Iwona
    Witek, Lukasz
    Olejek, Anita
    GINEKOLOGIA POLSKA, 2021, 92 (12) : 837 - 843
  • [9] Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors
    De Giorgi, Ugo
    Casadei, Chiara
    Bergamini, Alice
    Attademo, Laura
    Cormio, Gennaro
    Lorusso, Domenica
    Pignata, Sandro
    Mangili, Giorgia
    CANCERS, 2019, 11 (10)
  • [10] lncRNAs are novel biomarkers for differentiating between cisplatin-resistant and cisplatin-sensitive ovarian cancer
    Li, Qing
    Zhang, Juan
    Zhou, Juan
    Yang, Binglie
    Liu, Pingping
    Cao, Lei
    Jing, Lei
    Liu, Hua
    ONCOLOGY LETTERS, 2018, 15 (06) : 8363 - 8370
12345